To tap into the promising growth opportunities within the biotech sector, investors can consider ETFs that provide exposure to leading industry players such as Eli Lilly and Company (NYSE:LLY), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), and Amgen Inc. (NASDAQ:AMGN).
We compiled our selection of the best performing biotech ETFs by ranking the top 10 based on their 5-year share price performance as of April 20, 2024, arranging them in ascending order for clarity. Additionally, we’ve provided insights into the top holdings of each ETF to enhance understanding for potential investors.
This post appeared at Insider Monkey.